The Canadian Rheumatology Association would like to advise its members of the following reported drug shortage:
Drug Name: CHLOROQUINE DIPHOSPHATE
Date Shortage Reported: July 2019
Expected Resolution of Shortage: No resolution expected. Officially termed an ‘Extended Disruption.’
Provinces Affected: All
While being called an ‘extended disruption’, this is really a discontinuation as the manufacturer (Teva) plans to discontinue it in Canada.
Some members and patients may still be able to access if local pharmacy has shelf stock.